EHLCATHOL – 101006744 – D6.2 - EHL-derived molecular surrogate compositionsGrant Agreement • November 2nd, 2022
Contract Type FiledNovember 2nd, 2022This document has been produced by the EHLCATHOL project, funded by the Horizon 2020 Programme of the European Community. The content presented in this document represents the views of the authors, and the European Commission has no liability in respect of the content.